I attended the 4th Annual Amoeba Summit this past Friday which was hosted by the Jordan Smelski Foundation.

The list of speakers was incredible, the biggest experts on Naegleria fowleri in the country, talking about topics ranging from lab diagnosis to the latest research and everything in between.

In this short interview, I talk to Medical Epidemiologist with the CDC, Jennifer Cope, MD, about the latest on the amoeba incidence and geography both in the US and internationally.


Naegleria fowleri: Study on death estimates, treatment success and the northward expansion of infections

Naegleria fowleri: An interview with Dr Jennifer Cope

Image/Robert Herriman

Naegleria fowleri and the Jordan Smelski Foundation for Amoeba Awareness

Naegleria fowleri, Acanthamoeba species and Balamuthia mandrillaris: Uncommon, accidental, yet high consequence

Balamuthia, neti pots and a unique case report

Balamuthia mandrillaris: Koral Reef’s story

Japanese encephalitis and the new vaccine recommendations

Ebola, PHEIC and the World Bank with Laurie Garrett

Malaria epidemic in Venezuela: 2.5 million cases predicted for 2020

Malaria drug resistance: An alternative for detection in the field

Rabies: Signs and symptoms, exposure, transmission and diagnostics

Ebola: Pathology, treating patients and the current outbreak

Medical history: Vaccines and Immunity